Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Moderate and Severe Knee Osteoarthritis
NCT02722811Unknown
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Feb 2016
- Primary completion
- Jul 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Randomised, open-label trial of etanercept in knee osteoarthritis (OA), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Pain Visual Analogue Scale at 12 weeks. Status: unknown.
02
Drugs
etanercept
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02722811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722811.